Calliditas Therapeutics Ab carries a market capitalization of 19.80M, placing it among publicly traded companies globally.
| Market Cap | 19.80M |
| Enterprise Value | N/A |
Calliditas Therapeutics Ab's stock has declined approximately -87.14786% over the past 52 weeks. The 50-day moving average sits at 1.77, while the 200-day moving average is 2.85.
| Beta (5Y) | N/A |
| 52-Week Price Change | -87.14786% |
| 50-Day Moving Average | 1.77 |
| 200-Day Moving Average | 2.85 |
| Average Volume (20 Days) | N/A |